U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07950631) titled 'Colistin Use in Neonates ICU Patients With Gram Negative Resistant Infection' on Nov. 16.

Brief Summary: Prospective study evaluating the pharmacokinetics of colistin after IV administration of colistin different doses

Study Start Date: Dec. 16, 2024

Study Type: OBSERVATIONAL

Condition: Sepsis

Intervention: DRUG: Polymyxin E (Colistin)

1. Evaluation of neonatal efficacy of different administered doses of IV colistin in neonatal sepsis.

2. Assessment of colistin related AKI rates in NICU.

3. Development of personalized approach for dose selection in neonatal sepsis

4. Characterize pharmacokinetics parameters in neonates inc...